These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22574980)

  • 1. Cerebral aneurysm as an exacerbating factor in stroke pathology and a therapeutic target for neuroprotection.
    Tajiri N; Lau T; Glover LE; Shinozuka K; Kaneko Y; van Loveren H; Borlongan CV
    Curr Pharm Des; 2012; 18(25):3663-9. PubMed ID: 22574980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Progress in Therapeutic Strategies for Ischemic Stroke.
    Yamashita T; Abe K
    Cell Transplant; 2016; 25(5):893-8. PubMed ID: 26786838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating acute ischemic stroke.
    Fisher M; Bastan B
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies for acute ischemic stroke.
    Leker RR; Eichel R; Rafaeli G; Ben-Hur T
    Isr Med Assoc J; 2006 Nov; 8(11):788-92. PubMed ID: 17180832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
    Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
    Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural stem cell therapy for subacute and chronic ischemic stroke.
    Boese AC; Le QE; Pham D; Hamblin MH; Lee JP
    Stem Cell Res Ther; 2018 Jun; 9(1):154. PubMed ID: 29895321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke: Basic and Clinical.
    Singh TP; Weinstein JR; Murphy SP
    Adv Neurobiol; 2017; 15():281-293. PubMed ID: 28674985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
    Yu S; Liu X; Shen Y; Xu H; Yang Y; Ding F
    Neuroscience; 2016 Jul; 327():44-52. PubMed ID: 27060484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
    Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection in acute ischemic stroke.
    De Keyser J; Uyttenboogaart M; Koch MW; Elting JW; Sulter G; Vroomen PC; Luijckx GJ
    Acta Neurol Belg; 2005 Sep; 105(3):144-8. PubMed ID: 16255152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular protection and restorative therapy in ischemic stroke.
    Yamashita T; Deguchi K; Nagotani S; Abe K
    Cell Transplant; 2011; 20(1):95-7. PubMed ID: 20887680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can molecular and cellular neuroprotection be translated into therapies for patients?: yes, but not the way we tried it before.
    Tymianski M
    Stroke; 2010 Oct; 41(10 Suppl):S87-90. PubMed ID: 20876514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of ischemic stroke: relevance to stem cell therapy.
    Gilman S
    Exp Neurol; 2006 May; 199(1):28-36. PubMed ID: 16631744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection via AT
    Bennion DM; Steckelings UM; Sumners C
    Clin Sci (Lond); 2018 May; 132(10):1055-1067. PubMed ID: 29802210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
    Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
    Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell-paved biobridges facilitate stem transplant and host brain cell interactions for stroke therapy.
    Duncan K; Gonzales-Portillo GS; Acosta SA; Kaneko Y; Borlongan CV; Tajiri N
    Brain Res; 2015 Oct; 1623():160-5. PubMed ID: 25770817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental neuroprotection in ischemic stroke: a concise review.
    Rajah GB; Ding Y
    Neurosurg Focus; 2017 Apr; 42(4):E2. PubMed ID: 28366067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.